Luz, Martim
Ribeiro, M.
Alpalhão, M.
Silva, A. M.
Alves, J.
Brito, C.
Filipe, P.
Torres, Tiago https://orcid.org/0000-0003-0404-0870
Article History
Accepted: 23 March 2025
First Online: 13 April 2025
Declarations
:
: Not applicable.
: M.L., M.R., M.A., A.M.S., J.A., C.B., and P.F. have no conflict of interests. T.T. has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Amgen, Almirall, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius-Kabi, Janssen, LEO Pharma, Eli Lilly, MSD, Mylan, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme, Sandoz and UCB.
: The data that supports the findings of this article are available from the corresponding author upon reasonable request.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given the final approval for the version to be published.